153 related articles for article (PubMed ID: 3137272)
1. Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin.
Hessen MT; Pitsakis PG; Levison ME
J Infect Dis; 1988 Sep; 158(3):542-8. PubMed ID: 3137272
[TBL] [Abstract][Full Text] [Related]
2. Tolerance of Pseudomonas aeruginosa to killing by ciprofloxacin, gentamicin and imipenem in vitro and in vivo.
Davey P; Barza M; Stuart M
J Antimicrob Chemother; 1988 Apr; 21(4):395-404. PubMed ID: 3132439
[TBL] [Abstract][Full Text] [Related]
3. Comparative imipenem treatment of Staphylococcus aureus endocarditis in the rat.
Baumgartner JD; Glauser MP
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():79-87. PubMed ID: 6583198
[TBL] [Abstract][Full Text] [Related]
4. The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat.
Ingerman MJ; Pitsakis PG; Rosenberg AF; Levison ME
J Infect Dis; 1986 Apr; 153(4):707-14. PubMed ID: 2936832
[TBL] [Abstract][Full Text] [Related]
5. Postantibiotic effect of imipenem, alone and in combination with amikacin, on Pseudomonas aeruginosa.
Gerçeker AA; Otük G
Chemotherapy; 1995; 41(6):433-6. PubMed ID: 8529433
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa.
Thauvin C; Lecomte F; Le Boete I; Grise G; Lemeland JF
Infection; 1989; 17(1):31-4. PubMed ID: 2493429
[TBL] [Abstract][Full Text] [Related]
7. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
Scheld WM; Keeley JM
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():65-78. PubMed ID: 6421794
[TBL] [Abstract][Full Text] [Related]
8. Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections.
Davey PG; Barza M; Stuart M
J Infect Dis; 1987 Mar; 155(3):518-23. PubMed ID: 3100661
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
Chandrasekar PH; Levine DP; Price S; Rybak MJ
J Antimicrob Chemother; 1988 Apr; 21(4):461-9. PubMed ID: 3378959
[TBL] [Abstract][Full Text] [Related]
10. Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa.
Hostacká A
Arzneimittelforschung; 1997 Aug; 47(8):965-7. PubMed ID: 9296285
[TBL] [Abstract][Full Text] [Related]
11. Treatment with imipenem of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis.
Martínez F; Martín-Luengo F; Garcia A; Valdés M
J Antimicrob Chemother; 1994 Jun; 33(6):1201-7. PubMed ID: 7928813
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas endocarditis: cure with carbenicillin and polymyxin B.
Diaz CR; Fossieck BE; Parker RH
South Med J; 1977 Jul; 70(7):869-71. PubMed ID: 195349
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics.
Navas D; Caillon J; Gras-Le Guen C; Jacqueline C; Kergueris MF; Bugnon D; Potel G
J Antimicrob Chemother; 2004 Oct; 54(4):767-71. PubMed ID: 15317741
[TBL] [Abstract][Full Text] [Related]
14. The postantibiotic effect of meropenem and imipenem on selected bacteria.
Nadler HL; Pitkin DH; Sheikh W
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
[TBL] [Abstract][Full Text] [Related]
15. [Effect of superinhibitory levels of imipenem and amikacin singly or in combination on Pseudomonas aeruginosa].
Hostacká A
Epidemiol Mikrobiol Imunol; 1997 Dec; 46(4):155-7. PubMed ID: 9471306
[TBL] [Abstract][Full Text] [Related]
16. Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo.
Hessen MT; Pitsakis PG; Levison ME
Antimicrob Agents Chemother; 1989 May; 33(5):608-11. PubMed ID: 2502064
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies of investigational beta-lactams as possible therapy for Pseudomonas aeruginosa endocarditis.
Zar FA; Kany RJ
Antimicrob Agents Chemother; 1985 Jan; 27(1):1-3. PubMed ID: 3920956
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and treatment of endocarditis.
Donabedian H; Freimer EH
Am J Med; 1985 Jun; 78(6A):127-33. PubMed ID: 3890533
[TBL] [Abstract][Full Text] [Related]
19. Isolation and in-vitro and in-vivo characterisation of a mutant of Pseudomonas aeruginosa PAO1 that exhibited a reduced postantibiotic effect in response to imipenem.
Majcherczyk PA; Kunz S; Hattenberger M; Vaxelaire J; Zak O; O'Reilly T
J Antimicrob Chemother; 1994 Oct; 34(4):485-505. PubMed ID: 7646646
[TBL] [Abstract][Full Text] [Related]
20. Outer membrane proteins profiles of Pseudomonas aeruginosa after the post-antibiotic effect of imipenem.
Hostacká A; Karelová E
Microbios; 1997; 90(362):45-50. PubMed ID: 9301070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
